Research Summary
PD-L1 biomarker testing is a medical test used to evaluate the expression of the PD-L1 protein on the surface of tumor cells. PD-L1 (programmed death-ligand 1) is a protein expressed on many tumor cells and immune cells, and when it binds to the PD-1 receptor on T-cells, it can suppress immune responses, helping tumors evade immune surveillance. Therefore, the level of PD-L1 expression is often closely related to the tumor’s immune evasion mechanisms. By testing the expression of PD-L1 in tumor samples, physicians can determine whether certain immune checkpoint inhibitors, such as anti-PD-1 or anti-PD-L1 antibodies, are suitable for a patient’s treatment. PD-L1 biomarker testing plays a crucial role in cancer immunotherapy, particularly in the treatment of lung cancer, melanoma, and head and neck cancers.
According to WENKH research statistics, the global PD-L1 Biomarker Testing market size will reach 4,209 Million USD in 2025 and is projected to reach 33,323 Million USD by 2032, with a CAGR of 34.39% (2025-2032). Among them, the Asia-Pacific PD-L1 Biomarker Testing market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The global PD-L1 Biomarker Testing market is highly competitive, with key market players including Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences, etc. This report categorizes the competitive landscape of the global PD-L1 Biomarker Testing market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global PD-L1 Biomarker Testing market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global PD-L1 Biomarker Testing industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of PD-L1 Biomarker Testing and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of PD-L1 Biomarker Testing in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the PD-L1 Biomarker Testing market. By considering local policies, this report evaluates the market prospects of PD-L1 Biomarker Testing in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Product Segment
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Others
Product Application
Hospital
Diagnostic Center
Others
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global PD-L1 Biomarker Testing Industry Chain Analysis
Chapter 3: Global PD-L1 Biomarker Testing Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global PD-L1 Biomarker Testing Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global PD-L1 Biomarker Testing Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis
Chapter 7: North America PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 8: Europe PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 9: China PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 10: Asia Pacific (excluding China) PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 11: Latin America PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 12: Middle East and Africa PD-L1 Biomarker Testing Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Contents
1 PD-L1 Biomarker Testing Market Overview
1.1 Product Definition Introduction
1.2 Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis (2020-2032)
1.3 PD-L1 Biomarker Testing Market Status and Development Prospects
1.3.1 PD-L1 Biomarker Testing Market Status
1.3.2 PD-L1 Biomarker Testing Industry Development Prospects
1.4 PD-L1 Biomarker Testing Market Overview by Product Segment
1.4.1 Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 PD-L1 (22C3)
1.4.3 PD-L1(28-8)
1.4.4 PD-L1 (SP142)
1.4.5 PD-L1 (SP263)
1.4.6 Others
1.5 PD-L1 Biomarker Testing Market Overview by Product Application
1.5.1 Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Hospital
1.5.3 Diagnostic Center
1.5.4 Others
2 PD-L1 Biomarker Testing Industry Supply Chain Analysis
2.1 PD-L1 Biomarker Testing Supply Chain
2.2 PD-L1 Biomarker Testing Midstream Suppliers
2.3 PD-L1 Biomarker Testing Downstream Customers
2.4 PD-L1 Biomarker Testing Sales Channel Analysis
3 PD-L1 Biomarker Testing Market Environment Analysis
3.1 PD-L1 Biomarker Testing Industry Policy Analysis
3.2 PD-L1 Biomarker Testing Emerging Technology Trends in the Industry
3.3 PD-L1 Biomarker Testing Restraining Factors Analysis
3.4 PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global PD-L1 Biomarker Testing Market Players Competition Landscape
4.1 Global PD-L1 Biomarker Testing Market Revenue by Key Players (2021-2025)
4.2 Global PD-L1 Biomarker Testing Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global PD-L1 Biomarker Testing Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Agilent Technologies
5.1.1 Agilent Technologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Features
5.1.3 Agilent Technologies PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue by Product Segment
5.1.5 Agilent Technologies PD-L1 Biomarker Testing Revenue by Region
5.2 Roche
5.2.1 Roche Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Roche PD-L1 Biomarker Testing Product Features
5.2.3 Roche PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.2.4 Roche PD-L1 Biomarker Testing Revenue by Product Segment
5.2.5 Roche PD-L1 Biomarker Testing Revenue by Region
5.3 Merck
5.3.1 Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Merck PD-L1 Biomarker Testing Product Features
5.3.3 Merck PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.3.4 Merck PD-L1 Biomarker Testing Revenue by Product Segment
5.3.5 Merck PD-L1 Biomarker Testing Revenue by Region
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Features
5.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.4.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue by Product Segment
5.4.5 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue by Region
5.5 AstraZeneca
5.5.1 AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 AstraZeneca PD-L1 Biomarker Testing Product Features
5.5.3 AstraZeneca PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.5.4 AstraZeneca PD-L1 Biomarker Testing Revenue by Product Segment
5.5.5 AstraZeneca PD-L1 Biomarker Testing Revenue by Region
5.6 Ono Pharmaceutical
5.6.1 Ono Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Features
5.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.6.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue by Product Segment
5.6.5 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue by Region
5.7 Regeneron
5.7.1 Regeneron Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Regeneron PD-L1 Biomarker Testing Product Features
5.7.3 Regeneron PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.7.4 Regeneron PD-L1 Biomarker Testing Revenue by Product Segment
5.7.5 Regeneron PD-L1 Biomarker Testing Revenue by Region
5.8 Innovent
5.8.1 Innovent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Innovent PD-L1 Biomarker Testing Product Features
5.8.3 Innovent PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.8.4 Innovent PD-L1 Biomarker Testing Revenue by Product Segment
5.8.5 Innovent PD-L1 Biomarker Testing Revenue by Region
5.9 Hengrui Medicine
5.9.1 Hengrui Medicine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Features
5.9.3 Hengrui Medicine PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.9.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue by Product Segment
5.9.5 Hengrui Medicine PD-L1 Biomarker Testing Revenue by Region
5.10 Junshi Biosciences
5.10.1 Junshi Biosciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Features
5.10.3 Junshi Biosciences PD-L1 Biomarker Testing Product Revenue and Gross Margin Analysis (2021-2025)
5.10.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue by Product Segment
5.10.5 Junshi Biosciences PD-L1 Biomarker Testing Revenue by Region
6 Global PD-L1 Biomarker Testing Market Analysis by Regions, by Product Segment and Application
6.1 Global PD-L1 Biomarker Testing Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032
6.1.1 Global PD-L1 Biomarker Testing Market Revenue by Region (2020-2025)
6.1.2 Global PD-L1 Biomarker Testing Market Revenue Forecast by Region (2026-2032)
6.2 Global PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
6.3 Global PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
7 North America PD-L1 Biomarker Testing Market Analysis
7.1 North America PD-L1 Biomarker Testing Market Prospects
7.1.1 North America PD-L1 Biomarker Testing Market Revenue and Growth Forecast by Countries (2020-2032)
7.1.2 U.S.
7.1.3 Canada
7.2 North America PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
7.3 North America PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
8 Europe PD-L1 Biomarker Testing Market Analysis
8.1 Europe PD-L1 Biomarker Testing Market Prospects
8.1.1 Europe PD-L1 Biomarker Testing Market Revenue and Growth Forecast by Countries (2020-2032)
8.1.2 Germany
8.1.3 France
8.1.4 United Kingdom
8.1.5 Italy
8.1.6 Spain
8.1.7 Benelux
8.2 Europe PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
8.3 Europe PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
9 China PD-L1 Biomarker Testing Market Analysis
9.1 China PD-L1 Biomarker Testing Market Prospects
9.2 China PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
9.3 China PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
10 Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Analysis
10.1 Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Prospects
10.1.1 Asia Pacific (excl. China) PD-L1 Biomarker Testing Revenue and Growth Forecast by Countries (2020-2032)
10.1.2 Japan
10.1.3 South Korea
10.1.4 India
10.1.5 Southeast Asia
10.1.6 Australia
10.2 Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
10.3 Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
11 Latin America PD-L1 Biomarker Testing Market Analysis
11.1 Latin America PD-L1 Biomarker Testing Market Prospects
11.1.1 Latin America PD-L1 Biomarker Testing Revenue and Growth Forecast by Countries (2020-2032)
11.1.2 Mexico
11.1.3 Brazil
11.2 Latin America PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
11.3 Latin America PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
12 Middle East and Africa PD-L1 Biomarker Testing Market Analysis
12.1 Middle East and Africa PD-L1 Biomarker Testing Market Prospects
12.1.1 Middle East and Africa PD-L1 Biomarker Testing Revenue and Growth Forecast by Countries (2020-2032)
12.1.2 Saudi Arabia
12.1.3 South Africa
12.2 Middle East and Africa PD-L1 Biomarker Testing Market Size by Product Segment (2020-2032)
12.3 Middle East and Africa PD-L1 Biomarker Testing Market Size by Product Application (2020-2032)
13 Research Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.2 Research Landscape
14.3 Research Benchmark and Hypothesis
14.4 Data Source
14.4.1 Primary Sources
14.4.2 Secondary Sources
14.5 Data Cross Validation
14.6 Disclaimer
Table 1：Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：PD-L1 Biomarker Testing Downstream Customers List
Table 4：PD-L1 Biomarker Testing Distributors/Dealers List
Table 5：Global PD-L1 Biomarker Testing Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global PD-L1 Biomarker Testing Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global PD-L1 Biomarker Testing Market Expansion and M&A Dynamic
Table 9：Agilent Technologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Agilent Technologies PD-L1 Biomarker Testing Product Features
Table 11：Agilent Technologies PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：Agilent Technologies PD-L1 Biomarker Testing Revenue by Product Segment
Table 13：Agilent Technologies PD-L1 Biomarker Testing Revenue by Region
Table 14：Roche Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 15：Roche PD-L1 Biomarker Testing Product Features
Table 16：Roche PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 17：Roche PD-L1 Biomarker Testing Revenue by Product Segment
Table 18：Roche PD-L1 Biomarker Testing Revenue by Region
Table 19：Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 20：Merck PD-L1 Biomarker Testing Product Features
Table 21：Merck PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 22：Merck PD-L1 Biomarker Testing Revenue by Product Segment
Table 23：Merck PD-L1 Biomarker Testing Revenue by Region
Table 24：Bristol-Myers Squibb Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Bristol-Myers Squibb PD-L1 Biomarker Testing Product Features
Table 26：Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue by Product Segment
Table 28：Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue by Region
Table 29：AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 30：AstraZeneca PD-L1 Biomarker Testing Product Features
Table 31：AstraZeneca PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 32：AstraZeneca PD-L1 Biomarker Testing Revenue by Product Segment
Table 33：AstraZeneca PD-L1 Biomarker Testing Revenue by Region
Table 34：Ono Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 35：Ono Pharmaceutical PD-L1 Biomarker Testing Product Features
Table 36：Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 37：Ono Pharmaceutical PD-L1 Biomarker Testing Revenue by Product Segment
Table 38：Ono Pharmaceutical PD-L1 Biomarker Testing Revenue by Region
Table 39：Regeneron Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Regeneron PD-L1 Biomarker Testing Product Features
Table 41：Regeneron PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 42：Regeneron PD-L1 Biomarker Testing Revenue by Product Segment
Table 43：Regeneron PD-L1 Biomarker Testing Revenue by Region
Table 44：Innovent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 45：Innovent PD-L1 Biomarker Testing Product Features
Table 46：Innovent PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 47：Innovent PD-L1 Biomarker Testing Revenue by Product Segment
Table 48：Innovent PD-L1 Biomarker Testing Revenue by Region
Table 49：Hengrui Medicine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 50：Hengrui Medicine PD-L1 Biomarker Testing Product Features
Table 51：Hengrui Medicine PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 52：Hengrui Medicine PD-L1 Biomarker Testing Revenue by Product Segment
Table 53：Hengrui Medicine PD-L1 Biomarker Testing Revenue by Region
Table 54：Junshi Biosciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Junshi Biosciences PD-L1 Biomarker Testing Product Features
Table 56：Junshi Biosciences PD-L1 Biomarker Testing Revenue (Million USD) and Gross Margin (2021-2025)
Table 57：Junshi Biosciences PD-L1 Biomarker Testing Revenue by Product Segment
Table 58：Junshi Biosciences PD-L1 Biomarker Testing Revenue by Region
Table 59：Global PD-L1 Biomarker Testing Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)
Table 60：Global PD-L1 Biomarker Testing Market Revenue by Region (2020-2025) & (Million USD)
Table 61：Global PD-L1 Biomarker Testing Market Share by Region (2020-2025)
Table 62：Global PD-L1 Biomarker Testing Market Revenue Forecast by Region (2026-2032) & (Million USD)
Table 63：Global PD-L1 Biomarker Testing Market Share Forecast by Region (2026-2032)
Table 64：Global PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 65：Global PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 66：Global PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 67：Global PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 68：North America PD-L1 Biomarker Testing Market Revenue by Countries (2020-2025) & (Million USD)
Table 69：North AmericaPD-L1 Biomarker Testing Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 70：North America PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 71：North America PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 72：North America PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 73：North America PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 74：Europe PD-L1 Biomarker Testing Market Revenue by Countries (2020-2025) & (Million USD)
Table 75：Europe PD-L1 Biomarker Testing Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 76：Europe PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 77：Europe PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 78：Europe PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 79：Europe PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 80：China PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 81：China PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 82：China PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 83：China PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 84：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue by Countries (2020-2025) & (Million USD)
Table 85：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 86：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 87：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 88：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 89：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 90：Latin America PD-L1 Biomarker Testing Market Revenue by Countries (2020-2025) & (Million USD)
Table 91：Latin America PD-L1 Biomarker Testing Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 92：Latin America PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 93：Latin America PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 94：Latin America PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 95：Latin America PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 96：Middle East and Africa PD-L1 Biomarker Testing Market Revenue by Countries (2020-2025) & (Million USD)
Table 97：Middle East and Africa PD-L1 Biomarker Testing Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 98：Middle East and Africa PD-L1 Biomarker Testing Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 99：Middle East and Africa PD-L1 Biomarker Testing Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 100：Middle East and Africa PD-L1 Biomarker Testing Market Revenue by Product Application (2020-2025) & (Million USD)
Table 101：Middle East and Africa PD-L1 Biomarker Testing Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 102：Secondary Sources
Figure 1：PD-L1 Biomarker Testing Product Scope
Figure 2：Global PD-L1 Biomarker Testing Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global PD-L1 Biomarker Testing Product Segment Market Share (2025 & 2032)
Figure 4：Global PD-L1 Biomarker Testing Product Application Market Share (2025 & 2032)
Figure 5：PD-L1 (22C3) Product Scope
Figure 6：PD-L1(28-8) Product Scope
Figure 7：PD-L1 (SP142) Product Scope
Figure 8：PD-L1 (SP263) Product Scope
Figure 9：Others Product Scope
Figure 10：Hospital Product Scope
Figure 11：Diagnostic Center Product Scope
Figure 12：Others Product Scope
Figure 13：PD-L1 Biomarker Testing Industrial Chain Framework
Figure 14：Global PD-L1 Biomarker Testing Market by Geographic Segmentation in 2025
Figure 15：Global PD-L1 Biomarker Testing Market Share by Region (2020 VS 2025)
Figure 16：North America PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 17：North America PD-L1 Biomarker Testing Revenue Market Share by Countries (2025 VS 2032)
Figure 18：U.S. PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 19：Canada PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 20：Europe PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 21：Europe PD-L1 Biomarker Testing Revenue Market Share by Countries (2025 VS 2032)
Figure 22：Germany PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 23：France PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 24：United Kingdom PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 25：Italy PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 26：Spain PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 27：Benelux PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 28：China PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 29：Asia Pacific (excl. China) PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 30：Asia Pacific (excl. China) PD-L1 Biomarker Testing Revenue Market Share by Countries (2025 VS 2032)
Figure 31：Japan PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 32：South Korea PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 33：India PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 34：Southeast Asia PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 35：Australia PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 36：Latin America PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 37：Latin America PD-L1 Biomarker Testing Revenue Market Share by Countries (2025 VS 2032)
Figure 38：Mexico PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 39：Brazil PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 40：Middle East and Africa PD-L1 Biomarker Testing Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 41：Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries (2025 VS 2032)
Figure 42：Saudi Arabia PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 43：South Africa PD-L1 Biomarker Testing Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 44：Research Methodology
Figure 45：Primary Sources
Figure 46：Data Cross Validation
English
Related Reports 
